CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleRevenue is $866.59M, above the global median of $548.88M
- FinancialsAltman Z-Score 2.49: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.63%
Annual Rate
CNY 0.10Paid annual
Payout Ratio
17.8%Sustainable
Last Ex-Dividend
May 27, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.90BCNY880.42M · vs all stocks (USD)
Trailing P/E
26.34xvs Pharmaceutical Retailers peers
Revenue (TTM)
5.81BCNY866.59M · vs all stocks (USD)
Profit Margin
3.85%vs Pharmaceutical Retailers peers
Beta
0.7430xvs all stocks
52-Week Change
23.46%vs all stocks
Market Capitalization
5.90BCNY880.42M · vs all stocks (USD)
Enterprise Value
6.46BCNY963.76M · vs all stocks (USD)
Trailing P/E
26.34xvs Pharmaceutical Retailers peers
Price to Sales (TTM)
1.02xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
2.78xvs Pharmaceutical Retailers peers
Enterprise to Revenue
1.11xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
13.41xvs Pharmaceutical Retailers peers
Gross Margin
34.29%vs Pharmaceutical Retailers peers
Profit Margin
3.85%vs Pharmaceutical Retailers peers
Operating Margin
5.97%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
5.07%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
11.67%vs Pharmaceutical Retailers peers
Revenue (TTM)
5.81BCNY866.59M · vs all stocks (USD)
Revenue per Share (TTM)
14.57CNYUpdated Sep 21, 2026Quarterly Revenue Growth
13.50%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
2.00BCNY297.83M · vs all stocks (USD)
EBITDA (TTM)
466.22MCNY69.57M · vs all stocks (USD)
Net Income (TTM)
223.52MCNY33.35M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
33.00%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
715.16MCNY106.72M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
394.05MCNY58.80M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1000CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.63%vs all stocks
Payout Ratio
17.84%vs Pharmaceutical Retailers peers
Minority Interest (Equity)
66.13MCNYFY2025 · Dec 31, 2025Revenue
5.49BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
3.63BCNYFY2025 · Dec 31, 2025Gross Profit
1.86BCNYFY2025 · Dec 31, 2025Operating Income
412.96MCNY61.62M · vs all stocks (USD)
Pre-tax Income
294.39MCNYFY2025 · Dec 31, 2025Income Tax Expense
80.52MCNYFY2025 · Dec 31, 2025Net Income
213.87MCNYFY2025 · Dec 31, 2025EBIT
324.61MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
751.95MCNYFY2025 · Dec 31, 2025Research & Development
29.58MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
317.17MCNYFY2025 · Dec 31, 2025Other Operating Expenses
27.17MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
10.03MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
30.22MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4800CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
398.65MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
398.65MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
213.87MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-22.51MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-20.47MCNYFY2025 · Dec 31, 2025Free Cash Flow
-172.92MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
268.26MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
213.87MCNYFY2025 · Dec 31, 2025Other Non-cash Items
62.98MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-192.25MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-105.06MCNYFY2025 · Dec 31, 2025Capital Expenditures
-152.46MCNYFY2025 · Dec 31, 2025Net Acquisitions
-488.35MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.81BCNYFY2025 · Dec 31, 2025Sale of Investments
1.81BCNYFY2025 · Dec 31, 2025Other Investing Activity
469.99KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-647.15MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
734.35MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-516.68MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-56.75MCNYFY2025 · Dec 31, 2025Other Financing Charges
-380.57MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-219.65MCNYFY2025 · Dec 31, 2025Shares Outstanding
400.01MSharesUpdated Sep 21, 2026Float Shares
142.08MSharesUpdated Sep 21, 2026% Held by Insiders
64.55%vs all stocks
% Held by Institutions
4.32%vs all stocks
Total Cash (MRQ)
1.03BCNY154.13M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.58CNYUpdated Sep 21, 2026Total Debt (MRQ)
1.54BCNY229.27M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.7068xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
1.08xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
5.30CNYUpdated Sep 21, 2026Total Assets
5.49BCNY818.97M · vs all stocks (USD)
Total Current Assets
2.91BCNYFY2025 · Dec 31, 2025Total Liabilities
3.33BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.58BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
639.67MCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.69BCNYFY2025 · Dec 31, 2025Cash
260.11MCNYFY2025 · Dec 31, 2025Cash Equivalents
694.44MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
954.55MCNYFY2025 · Dec 31, 2025Other Short-term Investments
22.00MCNYFY2025 · Dec 31, 2025Accounts Receivable
565.83MCNYFY2025 · Dec 31, 2025Inventory
1.05BCNYFY2025 · Dec 31, 2025Accounts Payable
1.67BCNYFY2025 · Dec 31, 2025Short-term Debt
724.37MCNYFY2025 · Dec 31, 2025Other Current Liabilities
9.96MCNYFY2025 · Dec 31, 2025Long-term Debt
627.16MCNYFY2025 · Dec 31, 2025Common Stock (Book)
400.01MCNYFY2025 · Dec 31, 2025Retained Earnings
724.04MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.16BCNY322.78M · vs all stocks (USD)
Treasury Stock
0.00CNYFY2025 · Dec 31, 202552-Week Low
12.17CNYUpdated Sep 21, 202652-Week High
29.76CNYUpdated Sep 21, 202652-Week Change
23.46%vs all stocks
Beta
0.7430xvs all stocks
50-Day MA
14.88CNYUpdated Sep 21, 2026200-Day MA
17.89CNYUpdated Sep 21, 2026Avg 10-Day Volume
6.64MSharesUpdated Sep 21, 2026Avg 30-Day Volume
13.50MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.5600CNYUpdated Sep 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.49: grey zoneSignificant
Altman Z-Score: 2.49
Low earnings qualitySignificant
Earnings Quality Score: -1.24
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Revenue is $866.59M, above the global median of $548.88MNotable
Revenue (USD): 866,590,532.536Global Median: 548,883,780.48
Levered free cash flow is $58.8M, above the global median of $18.73MNotable
Levered free cash flow (USD): 58,799,809.135Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Shanghai Waigaoqiao Free Trade Zone Development Co. Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Sanjiang Shopping Club Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
Aoki Holdings Inc.
Tier 1FlowUnit ReplicationRiskInterface
Ningbo Peacebird Fashion Co., Ltd.
Tier 1FlowUnit ReplicationRiskInterface
OceanPact Servicos Maritimos S.A.
Tier 1FlowUnit ReplicationProductionRule
Idom Inc.
Tier 1FlowUnit ReplicationInterfaceRisk
Chengdu Hongqi Chain Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
V2 Retail Ltd.
Tier 1FlowUnit ReplicationRiskInterface
Yixintang Pharmaceutical Group Co. Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Fujian Zhangzhou Development Co., Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Tianjin Ringpu Bio-Technology Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Shenzhen Inovance Technology Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Five-Star Business Finance Limited
1 interpretationMulti-Year Revenue, Profit, And Income Growth